Clinical trial
Velcade Combined With High-Dose Dexamethasone in Patients With Newly Diagnosed…
NCT00337506 · Nantes University Hospital, Other · Terminated
Key facts
| NCT number | NCT00337506 |
|---|---|
| Title | Velcade Combined With High-Dose Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma |
| Official title | A Multicenter Open-Label Phase II Study of Velcade Combined With High-Dose Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma |
| Lead sponsor | Nantes University Hospital, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Multiple Myeloma |
| Intervention type | Drug |
| Interventions | Dexamethasone, velcade |
| Enrollment | 50 |
| Start date | Aug 1, 2003 |
| First posted | Jun 16, 2006 |
| Last update posted | Jun 16, 2006 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: